
Celemics, Inc. — Investor Relations & Filings
Celemics, Inc. is a biotechnology company that develops and provides Next-Generation Sequencing (NGS) solutions for research and clinical applications. The company specializes in hybridization-based target enrichment technology, offering a comprehensive portfolio of products and services. This includes ready-to-use and customized NGS panels, whole exome sequencing kits, library preparation kits, modular accessories, and bioinformatics analysis services. Celemics' solutions support a wide range of fields, including oncology (somatic cancer, liquid biopsy), inherited diseases, pathogen analysis, pharmacogenomics, and immune repertoire profiling. A key focus is the development of end-to-end customized target enrichment panels, providing support from assay design and optimization to complete bioinformatics analysis. The company's proprietary technologies in probe design and molecular barcoding enable efficient analysis of diverse and challenging sample types.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [기재정정]주요사항보고서(유상증자결정) | 2026-05-21 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| [기재정정]주요사항보고서(유상증자결정) | 2026-05-12 | Korean | |
| 주식등의대량보유상황보고서(약식) | 2026-05-08 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2026-05-07 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-07 | Korean |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46726114 | [기재정정]주요사항보고서(유상증자결정) | 2026-05-21 | Korean | ||
| 46362816 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 45154650 | [기재정정]주요사항보고서(유상증자결정) | 2026-05-12 | Korean | ||
| 43872782 | 주식등의대량보유상황보고서(약식) | 2026-05-08 | Korean | ||
| 42372145 | 주식등의대량보유상황보고서(일반) | 2026-05-07 | Korean | ||
| 42371922 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-07 | Korean | ||
| 41760605 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-06 | Korean | ||
| 41751513 | 주식등의대량보유상황보고서(일반) | 2026-05-06 | Korean | ||
| 39056797 | 기업설명회(IR)개최 | 2026-04-30 | Korean | ||
| 39034176 | 증권발행결과(자율공시) | 2026-04-30 | Korean | ||
| 38424821 | [기재정정]증권발행결과(자율공시) | 2026-04-29 | Korean | ||
| 38424772 | [기재정정]증권발행결과(자율공시) | 2026-04-29 | Korean | ||
| 38258404 | [기재정정]주요사항보고서(전환사채권발행결정) | 2026-04-29 | Korean | ||
| 37929249 | 증권발행결과(자율공시) | 2026-04-28 | Korean | ||
| 35175914 | [기재정정]주요사항보고서(유상증자결정) | 2026-04-22 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Changchun Bcht Biotechnology Co.
Biopharmaceutical firm focused on the R&D and production of…
|
688276 | CN | Manufacturing |
|
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD.
A diversified group focused on biopharmaceuticals, vaccines…
|
000661 | CN | Manufacturing |
|
Changzhou Qianhong Bio-pharma Co.,Ltd
Develops and manufactures heparin and enzyme biochemical me…
|
002550 | CN | Manufacturing |
|
Charlotte's Web Holdings, Inc.
Pioneer and market leader in whole-plant hemp-derived CBD w…
|
CWEB | CA | Manufacturing |
|
CHA Vaccine Research Institute
Develops vaccines and immunotherapeutics using proprietary …
|
261780 | KR | Manufacturing |
|
CHEIL BIO CO., LTD.
Develops and manufactures veterinary medicines and function…
|
052670 | KR | Manufacturing |
|
CHEMCLIN DIAGNOSTICS CO., LTD.
Develops IVD systems and reagents using proprietary LiCA te…
|
688468 | CN | Manufacturing |
|
Chemical Works of Gedeon Richter Plc
Vertically integrated pharma company focused on women's hea…
|
RICHT | HU | Manufacturing |
|
Chemokine Therapeutics Corp.
Developed chemokine-based therapies (peptide drugs) for can…
|
CHKT | CA | Manufacturing |
|
Chemomab Therapeutics Ltd.
Clinical-stage biotech developing therapeutics for fibro-in…
|
CMMB | US | Manufacturing |
Celemics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16444/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16444 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16444 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16444 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16444}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Celemics, Inc. (id: 16444)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.